Victorian Clinical Genetics Services (VCGS) welcomes the $500M allocation to investment in genomic research as part of the federal budget 2018.
The first research project ‘Mackenzie’s Mission’ is a $20M trial into pre-conception genetic carrier screening for serious genetic conditions like cystic fibrosis, spinal muscular atrophy and fragile X syndrome.
Our 'reproductive genetic carrier screen' (RGCS) has changed names and is now known as prepairTM.
The prepairTM genetic carrier screen gives individuals and couples information about their chance of having a child with cystic fibrosis (CF), fragile X syndrome (FXS) or spinal muscular atrophy (SMA). Regardless of family history, couples should be offered information about carrier screening before pregnancy. Awareness of carrier status prior to conception gives couples greater reproductive choice.